Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Private equity poised for rebound as $1tn in assets awaits deployment, says PwC
Private equity poised for rebound as $1tn in assets awaits deployment, says PwC Private equity firms are holding an estimated $1tn in unrealised assets amid delayed exits and macroeconomic headwinds, according to PwC’s 2025 midyear deal outlook. While limited...
Vista Equity increases stake in Assent at reported $1.3bn valuation
Vista Equity increases stake in Assent at reported $1.3bn valuation KPS Capital Partners has walked away from Vista Equity Partners has increased its investment in Ottawa-based supply chain management software firm Assent, in a deal that reportedly values the company...
KPS exits talks with Warburg Pincus over joint Gerresheimer bid
KPS exits talks with Warburg Pincus over joint Gerresheimer bid KPS Capital Partners has walked away from discussions with Warburg Pincus over a potential joint acquisition of Gerresheimer AG, according to a Bloomberg report citing people familiar with the matter. The...